News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Hohneker John
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/12/2023 |
4
| Hohneker John (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
01/24/2023 |
4
| Hohneker John (Director) has filed a Form 4 on CURIS INC
Txns:
| Granted 85,000 options to buy
@ $0.75, valued at
$63.8k
|
|
09/26/2022 |
4
| Hohneker John (Director) has filed a Form 4 on Aravive, Inc.
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2022 |
4
| Hohneker John (Director) has filed a Form 4 on CURIS INC
Txns:
| Granted 85,000 options to buy
@ $3.19, valued at
$271.2k
|
|
01/04/2022 |
4
| Hohneker John (Director) has filed a Form 4 on HUMANIGEN, INC
Txns:
| Granted 3,538 options to buy
@ $3.72, valued at
$13.2k
|
|
12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/20/2021 |
4
| Hohneker John (Director) has filed a Form 4 on HUMANIGEN, INC
Txns:
| Granted 42,866 options to buy
@ $6.56, valued at
$281.2k
|
|
10/20/2021 |
3
| Hohneker John (Director) has filed a Form 3 on HUMANIGEN, INC |
09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/29/2021 |
4
| Hohneker John (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns:
| Granted 31,380 options to buy
@ $16.65, valued at
$522.5k
|
|
01/29/2021 |
3
| Hohneker John (Director) has filed a Form 3 on Evelo Biosciences, Inc. |
11/07/2017 |
4
| Hohneker John (Director) has filed a Form 4 on Dimension Therapeutics, Inc.
Txns:
| Disposed/sold 38,000 options to buy
@ $4.6, valued at
$174.8k
|
|
01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|